IL10 and COVID-19: In this article, we present evidence supporting the non-classical pro-inflammatory effects of IL-10 as a driver of cytokine storms during COVID-19 and consider resistance to IL-10’s classical anti-inflammatory action as an alternative novel mechanism underlying elevated IL-10 levels in patients with severe COVID-19 (summarized in Figure 1).